Clinical trial · Interventional
CAR T-CELL Therapy Educational Video Trial
A Randomized Controlled Trial of an Educational Video Tool for Patients Receiving CAR T-Cell Therapy
NCT04280133CI-TRIAL-00063440unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to test a new educational video to help patients and doctors talk about CAR-T cell therapy, a treatment being used in cancer. \- Educational video tool for patients receiving CAR-T cell therapy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| CAR-T Cell Therapy | — | UNRESOLVED | — |
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Video Tool | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Educational Video Tool
- description
- Patients randomized to the intervention arm will watch a 3-minute video educational tool about CAR-T cell therapy prior to admission for CAR-T cell therapy.
- interventionNames
- Behavioral: Educational Video Tool
- type
- NO_INTERVENTION
- label
- Standard Care
- description
- Patients randomized to the control arm will receive usual care per the treating team. Any questions regarding CAR-T cell therapy will be directed to the patient's medical team
Primary outcomes (1)
- measure
- Feasibility (enrollment and retention rates)
- timeFrame
- Up to 1 year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years or age or older * Established diagnosis of a hematologic malignancy * Under consideration for CAR T-cell therapy at Massachusetts General Hospital Exclusion Criteria: * Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary oncologist believes prohibits informed consent or participation in the study * Undergoing CAR T-cell therapy for solid tumor malignancy * Inability to comprehend English, as the video is currently only available in English at this time
References
Publications (0)
Data not yet available
No reference posted for this study.